• call for care 214.379.2700

    Choice Cancer Care is here for you 9AM – 5PM Monday – Friday

    Inquiring after hours? Complete our contact form and we will be in touch as soon as possible.

    Call

  • Patientportal

    Access Your Portal To Health at Choice Cancer Care.

    Learn more about becoming a CCC Patient, including insurance information and patient rights, or login to access your personal portal for in-depth information about your health.

    LoginSign UpLearn More

  • get a second opinion

    Recent Diagnosis? Gain Confidence With A Second Opinion.

    Find out what to ask your doctor, what a second opinion could mean for you, and take the steps to get you on the right path to treat your cancer.

    Complete this form for a no obligation consultation:







    captcha

  • certified

    Choice Cancer Care is proud to be recognized by the Quality Oncology Practice Initiative (QOPI®) for excellence in quality, and safety in the administration of cancer care.

    Learn More

Focused Radiation Offers New Hope for Lung Cancer Patients

Lung cancer patients with small tumors may soon find a whole new treatment option open to them. A recent small-scale clinical trial showed that the application of focused radiation treatments in earlier stages of lung cancer could be as effective – if not more so – than riskier surgical procedures.

Focused radiation involves the application of a short-course targeted type of radiation that is designed to eliminate cancer cells while sparing nearby tissue. The procedure involves rather rapid treatments over consecutive days and does not require anesthesia or incisions. The benefits also include elimination of the risks that go hand-in-hand with traditional surgery meant to treat lung cancer tumors.

A small-scale clinical was recently conducted using the technique known as sterotactic ablative radiotherapy, or SABR. The treatment uses a robotic arm to increase precision and enables doctors to deliver radiation from multiple angles with a high level of accuracy. The end results of the study showed that this form of radiation is as good as common surgery for treating early-stage lung cancers.

The study involved 58 patients. Of that group, 31 patients had their tumors treated with the SABR technique. After three years, 30 of the 31 patients were still alive. In the surgical group, only 21 of 27 patients survived that long. The recurrence rate between the two groups was the same.

Although the clinical trial produced promising results, the jury is still out on the widespread application of this procedure. Larger clinical trials are still needed before the use of SABR goes widespread. Should the procedure continue to hold up to clinical scrutiny it could change the face of early-stage lung cancer treatment. Lung cancer is considered one of the fastest growing cancers in the United States with nearly half of all patients dying within a year of diagnosis. By eliminating the need for surgery, SABR may help increase cancer patients’ odds of survival while enabling them to enjoy a higher quality of life while enduring treatments.

Lung cancer patients with small tumors may soon find a whole new treatment option open to them. A recent small-scale clinical trial showed that the application of focused radiation treatments in earlier stages of lung cancer could be as effective – if not more so – than riskier surgical procedures.

Focused radiation involves the application of a short-course targeted type of radiation that is designed to eliminate cancer cells while sparing nearby tissue. The procedure involves rather rapid treatments over consecutive days and does not require anesthesia or incisions. The benefits also include elimination of the risks that go hand-in-hand with traditional surgery meant to treat lung cancer tumors.

A small-scale clinical was recently conducted using the technique known as sterotactic ablative radiotherapy, or SABR. The treatment uses a robotic arm to increase precision and enables doctors to deliver radiation from multiple angles with a high level of accuracy. The end results of the study showed that this form of radiation is as good as common surgery for treating early-stage lung cancers.

The study involved 58 patients. Of that group, 31 patients had their tumors treated with the SABR technique. After three years, 30 of the 31 patients were still alive. In the surgical group, only 21 of 27 patients survived that long. The recurrence rate between the two groups was the same.

Although the clinical trial produced promising results, the jury is still out on the widespread application of this procedure. Larger clinical trials are still needed before the use of SABR goes widespread. Should the procedure continue to hold up to clinical scrutiny it could change the face of early-stage lung cancer treatment. Lung cancer is considered one of the fastest growing cancers in the United States with nearly half of all patients dying within a year of diagnosis. By eliminating the need for surgery, SABR may help increase cancer patients’ odds of survival while enabling them to enjoy a higher quality of life while enduring treatments.

Cancer Screening Guidelines

Screening can help doctors discover and treat some types of cancer early. Usually, cancer treatment is more effective when the disease is detected in its early stages and there could be a better chance of curing the cancer. Some...

Learn More

Save Your Hair During Chemo

We offer the Chemo Cold Caps Solution for patients seeking to save their hair while undergoing chemotherapy.  The Chemotherapy Cold Caps program can be accessed at any of our North Texas clinics. At Choice Cancer Care we know that being diagnosed with...

Learn More

Learn About Your Options

Your journey with cancer is influenced by several factors. These factors include your overall condition, the specific characteristics of your cancer, and whether the goal of treatment is to eradicate your cancer, stop your cancer from spreading to other areas...

Learn More